Home » Authors » Jennifer Boggs

Jennifer Boggs

Articles

ARTICLES

Stressgen Cuts Staff, Saving Resources For HPV Vaccine

April 29, 2005

By Jennifer Boggs

Stressgen Cuts Staff, Saving Resources For HPV Vaccine

April 29, 2005

By Jennifer Boggs

Penwest's Beta-Blocker PW2101 Subject Of Prism Marketing Deal

April 28, 2005

By Jennifer Boggs

Penwest's Beta-Blocker PW2101 Subject Of Prism Marketing Deal

April 28, 2005

By Jennifer Boggs

OncoGenex In-Licenses Hsp27 Inhibitors For Isis Collaboration

April 27, 2005

By Jennifer Boggs

OncoGenex In-Licenses Hsp27 Inhibitors For Isis Collaboration

April 27, 2005

By Jennifer Boggs

Prestwick Seeks $75M IPO, Readies Tetrabenazine NDA

April 26, 2005

By Jennifer Boggs

Prestwick Seeks $75M IPO, Readies Tetrabenazine NDA

April 26, 2005

By Jennifer Boggs

Hamilton Pharmaceuticals' First Financing: $11M For CNS Drugs

April 25, 2005

By Jennifer Boggs

Hamilton Pharmaceuticals' First Financing: $11M For CNS Drugs

April 25, 2005

By Jennifer Boggs

View All Articles by Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...